Atrium Therapeutics (RNA)
Targets genetic drivers of rare cardiomyopathies with tissue-directed siRNA medicines.
$8.42
vs last close−0.80 (−8.68%)
Something off on this page? Send us feedback.
Next report
Nov 12, 26
estimated · in 50 days
EPS estimate
−$0.87
Revenue estimate
$15.0M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Aug '24Nov '24Feb '25May '25Feb '26May '26Aug '26Nov '26
Reported−$0.65−$0.65−$0.80−$0.90−$0.61−$0.97−$1.18Pending
Estimate−$0.79−$0.71−$0.79−$0.90−$1.24−$1.05−$1.42−$0.87
Surprise+17.7%+8.5%−1.3%0.0%+50.8%+7.6%+16.9%—
RevenueReportedEstimate
Aug '24Nov '24Feb '25May '25Feb '26May '26Aug '26Nov '26
Reported————$2.1M$19.6M$3.0MPending
Estimate$2.6M$4.1M$1.6M$2.4M$2.0M$2.0M$666.7K$15.0M
Surprise————+6.0%+881.8%+350.6%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2027 | −$1.86 | — | — |
| Sep 2027 | −$1.81 | — | — |
| Jun 2027 | −$1.73 | — | — |
| Mar 2027 | −$1.69 | — | — |
| Dec 2026 | −$1.55 | — | — |
| Nov 2026 | −$0.87 | — | — |
| Aug 2026 | −$1.42 | −$1.18 | +16.9% |
| May 2026 | −$1.05 | −$0.97 | +7.6% |
| Feb 2026 | −$1.24 | −$0.61 | +50.8% |
| May 2025 | −$0.90 | −$0.90 | 0.0% |
| Feb 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2027 | −$1.86 | — | — | $3.0M | — | — | — |
| Sep 2027 | −$1.81 | — | — | $3.0M | — | — | — |
| Jun 2027 | −$1.73 | — | — | $3.0M | — | — | — |
| Mar 2027 | −$1.69 | — | — | $3.0M | — | — | — |
| Dec 2026 | −$1.55 | — | — | $1.0M | — | — | — |
| Nov 12, 2026 | −$0.87 | — | — | $15.0M | — | — | — |
| Aug 13, 2026 | −$1.42 | −$1.18 | +16.9% | $666.7K | $3.0M | +350.6% | +4.1% |
| May 14, 2026 | −$1.05 | −$0.97 | +7.6% | $2.0M | $19.6M | +881.8% | −0.2% |
| Feb 26, 2026 | −$1.24 | −$0.61 | +50.8% | $2.0M | $2.1M | +6.0% | — |
| May 8, 2025 | −$0.90 | −$0.90 | 0.0% | $2.4M | — | — | — |
| Feb 27, 2025 | |||||||
| Nov 7, 2024 | |||||||
| Aug 9, 2024 | |||||||
| May 9, 2024 | |||||||
| Feb 28, 2024 | |||||||
| Nov 8, 2023 | |||||||
| Aug 8, 2023 | |||||||
| May 9, 2023 | |||||||
| Feb 28, 2023 |